Botanix Pharmaceuticals Ltd
BOT
Company Profile
Business description
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.
Contact
41 - 47 Colin Street
Suite 3
West PerthWA6005
AUST: +61 865552945
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
1
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,757.90 | 13.20 | -0.15% |
CAC 40 | 7,656.12 | 27.61 | -0.36% |
DAX 40 | 23,317.81 | 116.84 | -0.50% |
Dow JONES (US) | 42,171.66 | 44.14 | -0.10% |
FTSE 100 | 8,843.47 | 9.44 | 0.11% |
HKSE | 23,710.69 | 269.61 | -1.12% |
NASDAQ | 19,546.27 | 25.18 | 0.13% |
Nikkei 225 | 38,885.15 | 348.41 | 0.90% |
NZX 50 Index | 12,611.99 | 15.33 | -0.12% |
S&P 500 | 5,980.87 | 1.85 | -0.03% |
S&P/ASX 200 | 8,531.20 | 10.10 | -0.12% |
SSE Composite Index | 3,388.81 | 1.40 | 0.04% |